|Day Low/High||153.05 / 155.27|
|52 Wk Low/High||142.81 / 256.80|
Jim Cramer weighs in on Royal Caribbean, Allergan, Tyson Foods, Carrizo Oil & Gas, Valeant Pharmaceuticals, Okta, CRISPR Therapeutics and more.
Jim Cramer says the hope that the trade dispute with China can be worked out was the fuel for this rally.
Aimovig is the first treatment approved by the agency to prevent migraines by blocking the calcitonin gene-related peptide receptor.
Here's what you need to know now for Thursday, May 17.
The chief commercial officer's appearance at a Bank of America healthcare conference came a day after Allergan competitor Evolus said it had received a complete response letter regarding its application for Botox rival DWP-450.
Jim discusses Macy's quarter as a readthrough to Nordstrom, defense and North Korea, and more on the market!
The insurgent manager who helped engineer the Amazon-Whole Foods combination opened a window into his latest allocations, any of which could become campaigns. Here's a wrap up of his investments as well as new developments from Mick McGuire's Marcato Capital and Dan Loeb's Third Point.
The markets strongly rebounded this week as a few of the major averages pushed into positive year-to-date territory.
The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
The Dublin-based drugmaker will provide communications on the strategic review in 'weeks, not months,' Allergan CFO Matthew Walsh said at the Deutsche Bank healthcare conference.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with Aurobindo Pharma Ltd.
The stocks inexplicably fell even after they delivered good earnings.
-- AboutYourGut.com Provides Resources and Education Focused on Irritable Bowel Syndrome with Diarrhea (IBS-D), Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC) --
Jim discusses the trade tariff deadline extension, Emerson Electric's earnings, last night's interview with Allergan CEO Brent Saunders, Goldman Sachs, 3M and more!
Jim Cramer makes the calls on Alibaba, First American, Coherent, Ionis Pharmacuetical, Skechers USA, Corning, Bank of Internet and more.
Debra Cafaro, chairman and CEO of Ventas, tells Jim Cramer about the company's investment in university research facilities.
Brent Saunders, chairman and CEO of Allergan, talks to Jim Cramer about the company's drug pipeline, and Botox.
Love the banks, then hate the banks. Love the industrials? Nope, they're out, too. Jim Cramer says it's ugly, but he would use the weakness in the upside surprises.
Stocks finished lower as Wall Street processes a mega-merger between Sprint and T-Mobile US and as Walmart says it will sell its supermarket business in the U.K.
Allergan's bottom is going to take more time.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.